Jacob P. Lalezari - 07 Mar 2024 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Reporting relationship: Chief Executive Officer
Issuer ticker: CYDY
Reported as of: 07 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Mar 2024, 21:30:20 UTC
Prior SEC filing: 29 Nov 2023
Next SEC filing: 30 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Tyler Blok, attorney-in-fact for Jacob P. Lalezari

Key filing fact

Jacob P. Lalezari filed Form 4 for CytoDyn Inc. (CYDY) on 08 Mar 2024.

Key facts

This page summarizes Jacob P. Lalezari's Form 4 filing for CytoDyn Inc. (CYDY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Mar 2024, 21:30.

Change

Previous filing in this sequence was filed on 29 Nov 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYDY transaction Derivative

Non-qualified stock option (right to buy)

Award

Transaction value: $0
Shares: +3,000,000
Change %
Price: $0.000000
Shares after: 3,000,000
Date: 07 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,000,000
Exercise price: $0.2100
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option will vest and become exercisable in 48 monthly installments beginning on April 7, 2024 and ending on March 7, 2028, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.

SEC remarks

EX 24- Power of Attorney